Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Company A - Z | Products & Services | Press Releases | White Papers
 

Antibodies

Browse the list below for nri section companies for the latest white papers, videos, news and contact information.

  • View by Company
  • View by Gallery
  • Agrisera, High-Quality Polyclonal and Monoclonal Antibody Services
  • ImmunoPrecise Antibodies, Custom Monoclonal and Polyclonal Antibody Development
  • Pepscan Presto, Peptide Research Tools
  • Proteogenix, Recombinant Protein Production and Custom Monoclonal Antibodies and Custom Polyclonal Antibodies
  • Yorkshire Bioscience, Reagents, Consumables and Research for Molecular and Cell Biology
Free Newsletter Sign Up
For all the latest drugdevelopment industry news, sign up for our regular updates.


Latest Videos
Tissue Solutions Biomarkers Partnership
Tissue Solutions Biomarkers Partnership
An introduction to Tissue Solutions' services for drug development...
Getting drugs under your skin
Getting drugs under your skin
Using ultrasound waves, MIT engineers have found a way to enhance...
Eviplera – Treatment for HIV
Eviplera – Treatment for HIV
Eviplera is a single-pill regimen targeted at human immunodeficiency...
ikfe CRO - Full-Service Contract Research Organisation
ikfe CRO - Full-Service Contract Research Organisation
As a German-based full-service contract research organisation, ikfe...

See all videos


Latest White Papers

Use of the Fios Genomics Analysis Approach for Determining Immunity Pathways
Fios Genomics

Melusine Venom Libraries: Designed to Discover Tomorrow's Drugs
Bachem

Rubber Oligomers Now Available at Toxikon
Toxikon Europe

Cocrystals in the Pharmaceutical and Fine Chemicals Industry: From an Option to an Opportunity
Enantia

Oligosaccharides in Drug Discovery
GlycoMar

See all white papers


  • Latest News
  • Latest Press Releases

Prosonix commences Phase 2 study of chronic obstructive pulmonary disease drug candidate
Speciality pharmaceutical company Prosonix has began the PSX1002 Phase...

Jennerex completes enrolment in Phase 2b liver cancer trial of Pexa-Vec
Jennerex Biotherapeutics has announced completion of enrolment in Phase...

Sanofi and Regeneron announce positive Phase 2a Results of Dupilumab in Asthma patients
Dupilumab targets the alpha subunit of the interleukin 4 receptor...

AbbVie begins Phase 3 diabetic nephropathy study of atrasentan
Research-based biopharmaceutical company AbbVie has started Phase 3 in...

Pfizer ends inotuzumab ozogamicin Phase 3 non-Hodgkin lymphoma study
Pfizer has stopped the Phase 3 randomised, open-label study (B1931008)...

See all news

Proven Autoclave Design a Long Runner
Friday, May 17, 2013 by Priorclave Top-loading laboratory autoclaves are the longest serving stalwarts of...

Bachem Adds 11 New Research Products to Online Catalogue
Friday, May 17, 2013 by Bachem Bachem is continuously expanding and updating its extensive range...

Meet Biovian at BioTrinity 2013 - European Biopartnering and Investment Conference - 14-16 May 2013, Newbury, UK
Wednesday, May 15, 2013 by Biovian Meet Biovian at BioTrinity 2013 - European Biopartnering and...

New Mammalian cGMP Cell Banking Facility Commissioned by Fujifilm Diosynth Biotechnologies
Tuesday, April 30, 2013 by Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies has announced that it has commissioned...

Tissue Solutions to Exhibit at 2013 BIO International Convention, Booth 4438, Apr 22 - 25, 2013, in Chicago IL, US
Monday, April 22, 2013 by Tissue Solutions Tissue Solution invites pharmaceutical and biotech companies to visit...

See all press releases

Follow Us:
Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.